Zhou Lu, a municipal-level inheritor of the Huishan clay figurine like Yu, said that while the traditional version is ...

A green microscopic organism could be the next superfood, following in the footsteps of now popular staples like salmon and ...

Photo provided to] The 2025 Spring Festival Gala, as the first gala following the successful inclusion of the Chinese Sprin ...

NAMSA recently announced plans to acquire WuXi AppTec’s medical device testing operations in the U.S. As part of the agreement, NAMSA will take ownership of WuXi’s facilities in Minnesota and Georgia.

Fan Weiqu, 62, killed 35 in a car rampage in Zhuhai, while Xu Jiajin, 21, fatally stabbed eight at a vocational school in Wuxi. Both acts, rooted in personal grievances, highlight a rise in “revenge ...

BEIJING (AP) -- China has executed two men who committed deadly attacks that killed dozens in November and raised concerns about a surge in what are called "revenge on society crimes," state media ...

Also in November, 21-year-old Xu Jiajin killed eight people and injured 17 others in a stabbing attack at his vocational school in the eastern city of Wuxi. Police said Wu had failed his ...

Shares of WuXi group companies jumped Monday after ... investors are watching to see what the fate of the legislation--or any potential successor--will be under Trump after he takes office on ...

Objective: This study aimed to explore the participation of patients with severe mental disorders in community health service management and its influencing factors in Wuxi. Methods ... factors for ...

Plus, news about Neur­i­zon: WuXi AppTec di­vests again: The com­pa­ny is sell­ing its US med­ical de­vice test­ing op­er­a­tions, in­clud­ing fa­cil­i­ties in Min­neso­ta and ...

WuXi AppTec is parting ways with its U.S. medical device testing business, selling its two stateside locations to the Ohio-based regulatory consulting firm NAMSA. The deal includes facilities in ...

WuXi AppTec’s leadership played down concerns about reduced demand for glucagon-like peptide-1 receptor agonist (GLP-1RA) manufacturing after leading obesity player Eli Lilly released lower-than ...